Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01153035 · ClinicalTrials.gov registry record · NA
Excision Followed by Radiofrequency Ablation for Breast Cancer
A NA study of Breast Cancer, sponsored by University of Arkansas.
- Active
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 6
- Study locations
NCT01153035: Active NA study of Breast Cancer, sponsored by University of Arkansas.
NCT01153035 is a NA study of Breast Cancer that is active but no longer recruiting, run by University of Arkansas. The registered enrollment target is 104 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01153035, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by University of Arkansas.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer lumpectomy sites to extend the "final" negative margin and consequently decrease the rates of re-operation. During the initial breast conservation procedure (lumpectomy), immediately following routine surgical resection of the tumor, radiofrequency energy (RFA) is applied to the wall (bed) of the fresh lumpectomy cavity, thus extending tumor free margin radially beyond the volume of the resected specimen.
Primary Outcome
How many patients must go back for re-excision of margins
Conditions Studied
Interventions
- DEVICE Radiofrequency Ablation
Study Locations (6)
Arizona
- University of Arizona - Tucson
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
California
- Sharp Oncology (Comprehensive Breast Care of San Diego) - San Diego
Colorado
- Comprehensive Breast Care of Denver - Denver
Kansas
- The University of Kansas Cancer Center - Westwood
New York
- Columbia - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2010-06 |
| Est. Completion | 2027-06 |
| Phase | NA |
What the registry record for NCT01153035 still lists
NCT01153035 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Radiofrequency Ablation is the first listed.
NCT01153035 lists 6 locations in 6 states (Arizona, Arkansas, California).
Frequently Asked Questions
What is clinical trial NCT01153035 about?
NCT01153035 is a clinical study titled "Excision Followed by Radiofrequency Ablation for Breast Cancer". The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer lumpectomy sites to extend the "final" negative margin and consequently decrease the rates of re-operation. During the initial breast conservation procedure (lumpec...
What is the current status of trial NCT01153035?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2010-06. Estimated completion is 2027-06.
What conditions does trial NCT01153035 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT01153035?
The interventions under investigation include: Radiofrequency Ablation (DEVICE).
Who is sponsoring clinical trial NCT01153035?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01153035 being conducted?
This trial has 6 study locations across Arizona, Arkansas, California, Colorado, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01153035's enrollment target sits among peer trials
104 553rd of 1224 higher than 669 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia